• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home News & Updates Hepatitis Awareness Month Toolkit 2024

Hepatitis Awareness Month Toolkit 2024

May 2, 2024

In May, HepVu recognizes Hepatitis Awareness Month (HAM). This month provides plenty of opportunities to shed light on the hidden epidemic of viral hepatitis and encourage people to get tested, get vaccinated, and seek treatment through various platforms.

Please use the following resources to spread awareness and knowledge about the viral hepatitis epidemic in the U.S.

What is Viral Hepatitis?

Viral hepatitis is an infection that causes liver inflammation and damage. Millions of people in the U.S. are living with viral hepatitis, and thousands of new cases are reported every year.

According to the Department of Health and Human Services (HHS), 67% of people with Hepatitis B and 51% of people with Hepatitis C do not know they have the virus, preventing them from getting lifesaving care that can manage Hepatitis B and cure Hepatitis C. Without diagnosis, people with Hepatitis B are at risk for serious and potentially fatal health problems, including liver damage, cirrhosis, liver cancer, and liver failure. As of 2016, nearly half of liver cancer cases were attributable to Hepatitis C.

Viral hepatitis also disproportionately impacts underserved communities. Asian Americans and Pacific Islanders represent about 5% of the U.S. population, but almost half of all people living with Hepatitis B. Other disproportionately affected groups include American Indian/Alaskan Natives, non-Hispanic Black people, people who inject drugs, people living with HIV, people experiencing homelessness, and people born between 1945 and 1965. Additionally, Eastern and Southeastern states experienced the highest rates of Hepatitis C.

As of 2021, Hepatitis C cases have drastically increased. The number of acute Hepatitis C cases has doubled since 2014, and 57% of cases with risk information reported injection drug use, underscoring the role that ending the opioid epidemic plays in ending the viral hepatitis epidemic.

HAM, National Hispanic Hepatitis Awareness Day (May 15), and Hepatitis Testing Day (May 19) provide ample opportunities to spread awareness about the importance of getting tested, getting vaccinated, and seeking treatment. Together, we can empower people and communities to seek viral hepatitis care and help end this deadly epidemic.

Share our Infographics

Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn

Sample Tweets:

About viral hepatitis:

  • The viral hepatitis epidemic unknowingly affects millions of people across the U.S. This #HepatitisAwarenessMonth, encourage your family and friends to get tested, vaccinated, and treated: https://hepvu.org/news-updates/hepatitis-awareness-month-toolkit-2024/
  • Undiagnosed #hepatitis leads to high risk of liver damage, cirrhosis, liver cancer, and liver failure. Find viral hepatitis testing services near you: https://hepvu.org/services/#/ #HepatitisAwarenessMonth
  • #HepC is curable, and #HepB is manageable. Without diagnosis, it is impossible to treat both of these potentially fatal diseases. Get tested for viral #hepatitis today: https://hepvu.org/services/#/
  • Did you know? As of 2016, nearly half of liver cancer causes were related to #HepC. Learn more about #hepatitis during #HepatitisAwarenessMonth here: https://hepvu.org/news-updates/hepatitis-awareness-month-toolkit-2024/

Health Disparities:

  • People who inject drugs are particularly at risk for #HepC. From 2014 to 2021, 57% of risk-adjusted cases reported injection drug use. #HepatitisAwarenessMonth.
  • Asian Americans and Pacific Islanders account for nearly half of all people living with #HepB. During #HepatitisAwarenessMonth and #AAPIHeritageMonth, it is crucial to address the barriers that prevent AAPI communities from receiving #HepB treatment.
  • Health disparities greatly contribute to concentrations of viral #hepatitis among certain communities. This #HepatitisAwarenessMonth, we must acknowledge the need for resources and #hepatitis health equity.

National Hispanic Hepatitis Awareness Day, May 15:

  • Today is National Hispanic Hepatitis Awareness Day. #DYK between 2020 and 2021, #HepB increased among the Hispanic community? This #HepatitisAwarenessMonth and #NationalHispanicHepatitisAwarenessDay, it is crucial to shed light on Hispanic #hepatitis numbers.

Hepatitis Testing Day, May 19:

  • Continued #hepatitis testing and surveillance is essential to ending the viral #hepatitis epidemic. This #HepatitisTestingDay, find testing services near you: https://hepvu.org/services/#/
  • Did you know? The CDC recommends #HepB and #HepC testing for all adults over the age of 18 along with pregnant people during pregnancy. Find a testing site near you: https://hepvu.org/services/#/

Resources:

  • Stat News Op-ed: Viral hepatitis is a silent killer. It can’t be eliminated if it isn’t tracked
  • 2022 Viral Hepatitis Surveillance Status Report
  • HepVu Releases Injection-Involved Overdose Mortality Data
  • What’s New in Viral Hepatitis – April 2024
  • Hepatitis C Elimination and the Cherokee Nation
  • Frank Hood on Hepatitis B and the Importance of Viral Hepatitis Surveillance
  • Rita Isabel Lechuga on National Hispanic Hepatitis Awareness Day
  • Jim Macrae on Health Disparities in Viral Hepatitis Elimination
Share Facebook Twitter LinkedIn Email

Keep Reading

May 14, 2025

National Hispanic Hepatitis Awareness Day 2025 Toolkit

Read More

May 13, 2025

HepVu Annual Launch 2025 Toolkit

Read More

April 14, 2025

What's New in Viral Hepatitis - April 2025

Read More

February 20, 2025

What's New in Viral Hepatitis - February 2025

Read More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.